Time Schedule & Deadlines
Abstract Submission: 9 March 2012
Notification of Acceptance: 26 March 2012
Submission of Full Paper: 20 April 2012

Welcome from the Chair of the Forum

Welcome to the 2nd Electronic Conference on Pharmaceutical Sciences (ECPS 2012). The Conference covers research in key areas of opportunity and challenge in pharmaceutical sciences, including:

  • Advances in the solid state field
  • Nanotechnology for drug delivery
  • Design and processing of protein and peptide formulation
  • Innovations in pharmaceutical manufacturing
  • Imaging in drug and dosage form development
  • Physiologically relevant in vitro models

Participants in this multidisciplinary conference will be able to examine, explore and critically engage with issues and advances in these and related areas. We hope to facilitate debates on these topics from academic and industrial perspectives, which will contribute to making drug development globally more successful and efficient.

A special feature of the Conference is that it is an electronic conference. This type of conference is particularly appropriate and useful for pharmaceutical research because the area is progressing rapidly, while activities in industry and academia are simultaneously becoming increasingly globalized. Successful research therefore requires interaction with individuals and groups around the world, demonstrating the need for new types of communication within our community. An electronic conference provides a platform for rapid and direct exchanges about the latest research findings, as well as a possibility for global meetings with no limitations related to traveling. To further remove barriers to "attendance", participation in the Conference as an author or other participant is free of charge.

The 2nd Electronic Conference on Pharmaceutical Sciences will be held at http://www.sciforum.net/conf/ecps2012, on a platform developed by MDPI to organize electronic conferences.

The 2nd Electronic Conference on Pharmaceutical Sciences is sponsored by MDPI and the scientific journal Pharmaceutics. Accepted papers will be published in the proceedings of the Forum, and selected papers will be published in Pharmaceutics.

I am very grateful to attendees, in particular authors, members of the Scientific Advisory Committee, session chairs and organizers.

I hope that your participation in the 2nd Electronic Conference on Pharmaceutical Sciences will prove to be interesting, enjoyable and above all beneficial.

 

Dr Clare Strachan
Chair of the 2nd Electronic Conference on Pharmaceutical Sciences
School of Pharmacy, University of Otago, New Zealand
Faculty of Pharmacy, University of Helsinki, Finland

Dr Clare Strachan completed a PhD in 2005 at the University of Otago (in collaboration with the University of Cambridge) and subsequently became a post doctoral researcher and then group leader at the Centre for Drug Research, University of Helsinki, Finland. She is currently a Senior Lecturer at the School of Pharmacy, University of Otago and has recently accepted a position at the Faculty of Pharmacy, University of Helsinki as an Assistant Professor. She has supervised numerous postgraduate researchers, including six PhD researchers to completion and another seven currently. She has published over 60 articles in international peer-reviewed scientific journals, and has active collaborations with researchers at various universities in Europe and the USA. She has been invited to present at pharmaceutical and spectroscopic conferences around the world. In 2011, she was awarded a University of Otago 2011 Early Careers Award for Distinction in Research.

Dr Clare Strachan’s main research interests involve the physico-chemical characterisation of solid drugs and dosage forms. In particular she has used traditional and novel spectroscopic methods to understand solid state forms of drugs and excipients and changes during manufacturing, storage and dissolution. The main spectroscopic techniques she has used are infrared, near-infrared, Raman, terahertz pulsed spectroscopy. Spatially resolved analysis has involved Raman mapping and coherent anti-Stokes Raman microscopy. Analysis of these data is supported by various chemometrics approaches, both qualitative and quantitative, and computational chemistry methods including ab initio calculations.